EMILY BAERTSCH: Open Payments
NPI 1225669211 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 24 payments from 4 companies in 2025. Trend: 2023 $509 · 2024 $483 · 2025 $694
Food & beverage: $694
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $198 |
| ABBVIE INC. | 11 | $174 |
| Madrigal Pharmaceuticals | 3 | $170 |
| Janssen Biotech, Inc. | 2 | $152 |
Products named: ENTYVIO, REZDIFFRA, TREMFYA, RINVOQ, MAVYRET, SKYRIZI.
Industry payments across SD — which companies pay providers there.
